가짜 및 불량 의약품 논란 속에서 전문가는 필리핀의 의약품 감독을 강화하기 위해 보건 전문가에 대한 전문 훈련을 촉구한다. 자민 박 박사는 의사들이 인구 수준의 결정을 자동으로 할 수 있는 능력이 없다고 주장한다. 이는 건강 문해력이 낮은 사회에서 매우 중요하다.
필리핀대학교 공중보건대학원 겸임교수이자 싱가포르 힐 벤처 랩 매니징 파트너인 자민 박 박사는 의약품 취급에 대한 전문 훈련의 필요성에 대해 의견을 밝혔다. 2026년 2월 5일 Rappler에 게재된 그의 글에서 최근 가짜 및 불량 의약품 관련 스캔들이 공분을 불러일으키고 엄격한 집행을 요구하고 있지만, 이는 부족하다고 주장한다.
AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨
A new national survey and a string of coercion cases are intensifying calls from Republican lawmakers, state attorneys general, and advocacy groups for the FDA to restore tighter safeguards on abortion medications—pressure that comes even as federal health officials say they are reviewing mifepristone’s safety and the FDA has cleared a second generic version.
In an RND interview, Federal Medical Association President Klaus Reinhardt discusses Germany's high doctor visit rates, which he does not attribute solely to patient behavior. He warns against planned prescribing rights for pharmacists and advocates for a sugar tax as well as smartphone bans in schools. Additionally, he supports a new regulation of assisted suicide with strict protective measures.
AI에 의해 보고됨
In San José de las Lajas, an early line formed outside the La Micro neighborhood pharmacy upon the arrival of scarce medicines. Residents, including retirees and teachers, prioritize treatments for chronic illnesses over food purchases, underscoring Cuba's prolonged shortages. This scene illustrates how daily life is restructured around medical scarcity.
Egypt's Health Minister Khaled Abdel Ghaffar announced the release of the first procedural guide for the state-funded medical treatment program in January 2026, aimed at standardizing services and streamlining approvals. This step underscores Egypt's commitment to citizens' constitutional right to equitable and comprehensive healthcare, serving as a key pillar of the health system until universal health insurance is fully rolled out.
AI에 의해 보고됨
Egypt's Minister of Health and Population Khaled Abdel Ghaffar met Kazakhstan's ambassador to Egypt, Askar Zhenis, to discuss strengthening bilateral cooperation in healthcare and pharmaceutical manufacturing technology. Abdel Ghaffar emphasized Egypt's interest in expanding ties through the transfer of pharmaceutical manufacturing technologies and harmonizing Good Manufacturing Practice standards. The talks covered collaboration in pharmaceutical production, biotechnology, and public health initiatives.
Mohamed El-Shimy, Minister of the Public Enterprises Sector, stated that the ministry places the highest priority on supporting its affiliated pharmaceutical companies through comprehensive development and modernisation programmes. These efforts aim to upgrade production lines, enhance operational efficiency, and adopt the latest technological systems. The initiatives are designed to meet domestic demand and strengthen competitiveness in export markets.
AI에 의해 보고됨
Nueva EPS announced the immediate activation of a network of pharmaceutical managers to ensure medicine delivery to its affiliates, following Colsubsidio's exit as operator starting January 1, 2026. This measure affects 1.6 million users in 11 departments across the country. The entity aims to prevent interruptions in medical treatments during the transition.